Bent Frandsen
Algemeen Directeur bij EXPRES2ION BIOTECH HOLDING AB
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Willem Adriaan de Jongh | M | - |
Adaptvac ApS
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | 15 jaar |
Charlotte Dyring | M | 56 |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | 15 jaar |
Jakob Knudsen | M | 56 |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | 7 jaar |
Martin Jensen | M | 64 |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | 15 jaar |
Allan Rosetzsky | M | 76 |
Adaptvac ApS
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | 14 jaar |
Gitte L. Pedersen | F | 61 |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | - |
Keith Alexander | M | 48 | 4 jaar | |
Karin Garre | M | 67 | 3 jaar | |
Sara Sande | F | 49 | 3 jaar | |
Farshad Guirakhoo | M | 70 | 1 jaar | |
Max M. Søgaard | M | - | 11 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Michael Rosenvold | M | 57 |
Copenhagen Business School
| 6 jaar |
Jørgen Drejer | M | 69 |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | 13 jaar |
Thomas Stig Plenborg | M | 57 |
Copenhagen Business School
| 4 jaar |
Steen Klysner | M | - | - | |
Henrik Jeppesen | M | - |
Copenhagen Business School
| 5 jaar |
Jan Fredskilde Andersen | M | 57 |
Copenhagen Business School
| 6 jaar |
Per Toelstang | M | 58 |
Copenhagen Business School
| 7 jaar |
Mats Gunnar Pettersson | M | 78 |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | 4 jaar |
Morten Hultberg Buchgreitz | M | 57 |
Copenhagen Business School
| 1 jaar |
Thomas Kirk Vilsbøll | M | 57 |
Copenhagen Business School
| 1 jaar |
Carsten Nielsen | M | - |
Copenhagen Business School
| 4 jaar |
Christian Poulsen | M | 58 |
Copenhagen Business School
| 4 jaar |
Stina Bjerg Nielsen | F | - |
Copenhagen Business School
| 4 jaar |
Søren Svendsen | M | 58 |
Copenhagen Business School
| 1 jaar |
Rene Spurré | M | - |
Copenhagen Business School
| 4 jaar |
Eske Rygaard-Hjalsted | M | - | 1 jaar | |
Henriette Fenger Ellekrog | F | 58 |
Copenhagen Business School
| 1 jaar |
Claus Due Pedersen | M | - |
Copenhagen Business School
| 4 jaar |
Siggi Saevarsson | M | - |
Copenhagen Business School
| 3 jaar |
Karsten Winther | M | 54 |
Copenhagen Business School
| 4 jaar |
Charlotte Blicher | F | - |
Copenhagen Business School
| 3 jaar |
Mette Thorn | M | - | 2 jaar | |
Eivind Hauglie-Hansen | M | - |
Copenhagen Business School
| 1 jaar |
Jesper Fors Holmark | M | 58 |
Copenhagen Business School
| 4 jaar |
Pernille Erenbjerg | F | 57 |
Copenhagen Business School
| 1 jaar |
Bent Moltved | M | - |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | 12 jaar |
Jesper Brandgaard | M | 60 |
Copenhagen Business School
| 2 jaar |
Tonny Andersen | M | 59 |
Copenhagen Business School
| 4 jaar |
Annemette Nøhr | F | 61 |
Copenhagen Business School
| 1 jaar |
Thomas Videbaek | M | 63 |
Copenhagen Business School
| 4 jaar |
Jørgen Buus Lassen | M | 90 |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | 9 jaar |
Jens Hesselberg Lund | M | 54 |
Copenhagen Business School
| 5 jaar |
Henrik Jeberg | M | - |
Copenhagen Business School
| 3 jaar |
Helle Bjerre | F | 57 |
Copenhagen Business School
| 4 jaar |
Rúni Hansen | M | 57 |
Copenhagen Business School
| 1 jaar |
Heidi Birgitte Nielsen | F | 60 |
Copenhagen Business School
| 4 jaar |
Philip Kusk | M | - |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | 12 jaar |
Hans-Christian Olesen | M | 56 |
Copenhagen Business School
| 4 jaar |
Hans Peter Holst | M | 82 |
Copenhagen Business School
| 2 jaar |
Per Madsen | M | 56 |
Copenhagen Business School
| 1 jaar |
Bjarke Pålsson | M | 56 |
Copenhagen Business School
| 1 jaar |
Stein-Tore Nybrodahl | M | 59 |
Copenhagen Business School
| 1 jaar |
Mattis Ranthe | M | - | 1 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Denemarken | 54 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Bent Frandsen
- Persoonlijk netwerk